Article

Dellann Elliott Mydland on Testing Brain Tumor Tissue

Author(s):

Dellann Elliott Mydland

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses testing brain tumor tissue before surgery.

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses testing brain tumor tissue before surgery.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Image of woman with text.
Image of man with text.
Image of Staci.
Image of woman, with text.
Image of woman with text.
Related Content
After surviving brain surgery, I found clarity, strength, and unexpected joy: © stock.adobe.com.
July 31st 2025

A Little Off the Top: the First Step in a Brain Cancer Journey

Bren Ohta, PhD, MS, LCSW
After surviving brain surgery, I found clarity, strength, and unexpected joy; facing my fears became the turning point, not the diagnosis.
Site Logo
July 31st 2025

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
Image of brain.
July 31st 2025

My Invisible Illness: Living With Brain Fog After Brain Tumor Surgery

Kristen Stewart
Even six years after brain tumor surgery, invisible symptoms like brain fog and memory loss shape how I live, cope, and find gratitude every day.
Site Logo
July 31st 2025

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
Image of clinical trial.
July 31st 2025

New Trials Target Brain, Bladder, Ovarian and Other Cancers

Spencer Feldman
New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with limited treatment paths.
Image of brain tumor.
July 31st 2025

FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas

Spencer Feldman
The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.